Genomics Market by Product (Instruments), by Application (Diagnostics), by Technology (PCR) Expected to Reach $22.1 Billion by 2020: Grand View Research, Inc
Market Size – $11.1 Billion in 2013, Market Growth – CAGR of 10.3%, Market Trends – Growing usage rates of DNA sequencing technology. View full report with TOC – http://www.grandviewresearch.com/industry-analysis/genomics-market.
San Francisco, California (PRWEB) August 12, 2014
The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital-acquired infections, is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.
Genomics-based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics-based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population-based therapeutic solutions and subsequent increase in R&D initiatives.
The report “Genomics Market Analysis By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized Medicines, Drug Discovery & Development, Academic Research, Agricultural), By Technology (PCR, DNA Sequencing, DNA Microarrays, Nucleic Acid Extraction & Purification) And Segment Forecasts To 2020” is available now to Grand View Research customers at http://www.grandviewresearch.com/industry-analysis/genomics-market.
Request Free Sample of This Report: http://www.grandviewresearch.com/industry-analysis/genomics-market/request
Further key findings from the study suggest:
- Consumables dominated the genomics market in terms of share at over 50% in 2013 mainly due to increasing rates of commercial adoption of genomic testing for various applications especially in the field of drug discovery and development
- North America was the largest regional market in 2013, at over 35.0% owing to the presence of sophisticated healthcare infrastructure, high patient awareness levels, healthcare expenditure and relatively larger number of R&D exercises pertaining to drug discovery and development.
- Asia Pacific is expected to grow at the fastest CAGR of 12.7% from 2014 to 2020. Growing demand for cost effective clinical outsourcing and the presence of high unmet medical needs in emerging countries such as India and China are some of the factors attributing to the rapid market growth in this region.
- DNA sequencing is one of the most commonly used technologies in biological and medical research laboratories for various applications such as DNA-based phylogeny, DNA cloning, functional analysis of genes, genetic fingerprints identification, detection and diagnosis of hereditary and infectious diseases. On account of the growing demand for all these applications, this segment is expected to grow at the highest CAGR during the forecast period.
- Key industry participants of this market include Affymetrix, Inc., Agilent Technologies, BGI, Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen, Roche Diagnostics, Life Technologies and Cepheid.
Browse All Reports of This Category By Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
For the purpose of this study, Grand View Research has segmented the genomics market on the basis of product, application, technology and region:
- Genomics Product Outlook
- Genomics Application Outlook
• Personalized Medicines
• Drug Discovery and Development
• Academic Research
- Genomics Technology Outlook
• DNA Sequencing
• DNA Microarray
• Nucleic Acid Extraction and Purification
- Genomics Regional Outlook
• North America
• Asia Pacific
Browse All Ongoing Reports By Grand View Research: http://www.grandviewresearch.com/ongoing-reports
About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/.
Corporate Sales Specialist, USA
Grand View Research, Inc
Related Reports :
Atrial Fibrillation Market Analysis By Procedure (Pharmacological Drugs, Anti-arrhythmic, Anti-coagulant, Non-Pharmacological Treatments, Radiofrequency, HIFU, Cryoablation, Microwave, Laser, Catheter Ablation, Maze Surgery, Electric Cardioversion) And Segment Forecasts To 2020 – http://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry
The global market for atrial fibrillation procedures and products is expected to reach USD 16.17 billion by 2020 growing at a CAGR of 13.2%, according to a new study by Grand View Research, Inc. Growing incidences of atrial fibrillation, strokes and brain damage due to blood clots coupled with a growing global base of geriatric population is expected to be a key driver for this market.
mHealth Market Analysis And Segment Forecasts To 2020 – http://www.grandviewresearch.com/industry-analysis/mhealth-market
The global market for mHealth (Mobile health) is expected to reach USD 49,119.2 million by 2020, according to a new study by Grand View Research, Inc. Monitoring services is expected to remain the dominant and fastest growing market segment, with market revenue of USD 1,227.5 million in 2012, and an estimated CAGR of 49.7% from 2014 to 2020.
For the original version on PRWeb visit: http://www.prweb.com/releases/global-genomics-market/industry-trend-forecast/prweb12088429.htm